Phupinder Gill retired as CEO of CME Group in 2016, after four years running the firm’s day-to-day operations and implementing strategic initiatives to expand CME’s core business into new areas of listed, overthe-counter and emerging markets. He first joined the company in 1988.
From 2004 to 2012, Gill served as CME Group’s president and COO since 2004, where he oversaw the divisions responsible for products and services, technology, global operations, clearing, enterprise solutions, and research and product development.
From 2000 to 2003, Gill was managing director and president of CME Clearing. In 2003, he led the implementation of the company’s historic clearing agreement with the Chicago Board of Trade under which CME provided clearing and backoffice processing for all CBOT products. This agreement helped pave the way for the 2007 merger of the two institutions.
Previously, Gill was responsible for implementing the CLEARING 21 system and CME’s cross-margining arrangement with the Options Clearing Corporation.
Gill served on CME Group’s Board of Directors, as well as the board of the World Federation of Exchanges and WFE’s Regulatory Policy Committee. He continues to serve on the board of directors of First Midwest Bancorp Inc. and The Alexander Maxwell Grant Foundation.
What is Phupinder Gill's net worth?
The estimated net worth of Phupinder Gill is at least $912,000.00 as of June 17th, 2020. Mr. Gill owns 4,000 shares of CME Group stock worth more than $912,000 as of November 21st. This net worth evaluation does not reflect any other investments that Mr. Gill may own. Learn More about Phupinder Gill's net worth.
How do I contact Phupinder Gill?
Has Phupinder Gill been buying or selling shares of CME Group?
Phupinder Gill has not been actively trading shares of CME Group in the last ninety days. Most recently, Phupinder Gill sold 30,002 shares of the business's stock in a transaction on Monday, September 19th. The shares were sold at an average price of $110.00, for a transaction totalling $3,300,220.00. Following the completion of the sale, the chief executive officer now directly owns 116,222 shares of the company's stock, valued at $12,784,420. Learn More on Phupinder Gill's trading history.
Who are CME Group's active insiders?
CME Group's insider roster includes Timothy Bitsberger (Director), Charles Carey (Director), Elizabeth Cook (Director), Kathleen Cronin (Insider), Sunil Cutinho (Insider), Terrence Duffy (Chairman & CEO), Bryan Durkin (Director), Lynne Fitzpatrick (Senior Managing Director & Deputy CFO), Martin Gepsman (Director), Phupinder Gill (CEO), Daniel Glickman (Director), Julie Holzrichter (COO), Kevin Kometer (Insider), Timothy McCourt (Insider), Hilda Piell (Insider), John Pietrowicz (CFO), Derek Sammann (Insider), Terry Savage (Director), Terry Savage (Director), William Shepard (Director), Howard Siegel (Director), Dennis Suskind (Director), Jack Tobin (CAO), Sean Tully (Insider), Ken Vroman (Insider), and Julie Winkler (Insider). Learn More on CME Group's active insiders.
Are insiders buying or selling shares of CME Group?
In the last year, CME Group insiders bought shares 5 times. They purchased a total of 109 shares worth more than $22,402.94. In the last year, insiders at the financial services provider sold shares 16 times. They sold a total of 88,049 shares worth more than $18,813,672.55. The most recent insider tranaction occured on November, 4th when Director Martin J Gepsman sold 400 shares worth more than $89,168.00. Insiders at CME Group own 0.3% of the company.
Learn More about insider trades at CME Group. Information on this page was last updated on 11/4/2024.
